Investors Look to Moonshot Technology Companies for Big Returns

Amid the changing technological landscape, investors are beginning to wonder which companies are poised to revolutionize the market further. The answer may very well be a group of companies known as “the moonshots.” These are firms that are taking on seemingly impossible tasks with deep investor backing, visionary leadership, and a willingness to operate at the frontier of what science and engineering can achieve. As a result, they are high-risk, high-reward investments that have the potential to become very lucrative in the near future.

These moonshot companies stretch across multiple sectors and new frontiers of technology, including electric vehicles, autonomous defense systems, genetic engineering, nuclear fusion, and next-generation space infrastructure. The thread that unites them all is their unyielding ambition. Each of these companies has staked its existence on a bet that mainstream markets were not yet ready to make. As such, investors who get behind them are taking a gamble, but it could pay off significantly.

Artificial Intelligence: Race to General Intelligence

Over the past several years, Artificial Intelligence (AI) has become an increasingly valuable investment option. As the technology has evolved, new potential uses are being explored, with increasingly large budgets behind them. As such, many of these moonshot companies have gained attention for their innovation in the AI sector.

The funding activity reflects ongoing global growth in artificial intelligence infrastructure and services. It also signals something more fundamental: a market consensus that those who control the foundational models backing AI will hold a position akin to that of the operating systems of the personal computing era. That is a winner-take-most situation, and investors seem to be pricing it accordingly.

For example, companies such as OpenAI and Anthropic are utilizing unprecedented resources to explore the boundaries of what is possible with this new technology. Together, these companies represent a concentration of speculative capital in AI with few historical precedents outside the dot-com era; though supporters argue the underlying technology is substantially more transformative. Any of these might be the next trillion-dollar boom.

Defense Technology: The New Military-Industrial Complex

AI is far from the only industry for which this kind of big-budget, high-minded experimentation and potentially lucrative returns are possible. In tandem with the evolution of technological tools such as AI, the military-industrial complex, its pipeline, and how the workflow operates have all been drastically redefined in recent years. These changes have left the door wide open for new companies to enter and innovate in the space, such as Andruil Industries, the creator of the Oculus virtual reality headset.

Today, they have moved on from entertainment-based VR experiences to focus on developing AI-powered defense systems, including autonomous drones, surveillance platforms, and command-and-control software that operate with minimal human input.

Similarly, Shield AI is a defense technology firm whose work has been attracting significant investor attention. The San Diego-based company develops autonomous AI pilots capable of flying military aircraft without GPS or communications links.

What sets moonshot companies like these apart from more traditional defense contractors is their software-first approach. Legacy players in this sector are built around long hardware procurement cycles and cost-plus government contracts. In stark contrast, these forward-thinking new ventures have positioned themselves as a Silicon Valley-style disruptor: faster, leaner, and capable of deploying capability at a fraction of the traditional timeline.

The US Department of Defense has taken notice, awarding the company contracts for border surveillance, submarine systems, and drone interception technology. As the Pentagon accelerates its push toward autonomous systems, companies like Shield AI and Anduril are increasingly seen as critical infrastructure for the next generation of national security.

Energy and Space: The Long Game

Beyond technological advancements, there are other moonshot companies actively pursuing even larger goals, such as finding new energy alternatives or exploring the vast reaches of space in bold new ways.

For example, Commonwealth Fusion Systems is aiming for what many physicists consider the long shot: developing a commercially viable nuclear fusion reactor. The company’s SPARC reactor is designed to produce net energy gain through high-temperature superconducting magnets, which, if successful, would mark the first commercially viable fusion energy pathway in history.

Elsewhere, Relativity Space is rethinking how rockets are built. The Los Angeles-based company 3D-prints most of its launch vehicles, reducing part counts from hundreds of thousands to fewer than 1,000. Like Anduril in defense, Relativity is a software-era company entering a hardware-focused industry with the clear goal of lowering both costs and cycle times.

Genetic Engineering: Colossal Biosciences and the Resurrection Economy

Colossal Biosciences has pursued a path that sits at the intersection of biotechnology, conservation, and what its founders describe as “de-extinction.” Serial entrepreneur Ben Lamm and Harvard geneticist George Church co-founded the Dallas-based company.

A $200 million Series C round closed in January 2025, valuing the company at over $10 billion, and additional funding later brought the total capital raised to roughly $615 million. The company’s projects include genetic engineering efforts to revive species, most notably the woolly mammoth, the dodo, and the Tasmanian tiger (also known as the thylacine).

The commercial logic is less speculative than it may appear. Colossal’s core gene-editing technologies have applications well beyond resurrection biology. The CRISPR tools and genomic sequencing capabilities developed to reconstruct extinct species translate directly into advances in cancer research, agricultural biology, and pandemic preparedness.

Investors are effectively buying exposure to a platform technology through a narrative compelling enough to generate mainstream attention and scientific talent at scale.

But Colossal is not the only company repositioning the boundaries of biological possibility. Altos Labs, the cellular reprogramming company backed by Jeff Bezos and Yuri Milner, has raised over $3 billion to pursue research into reversing cellular aging. The company’s work centers on Yamanaka factors, proteins that can reset cells to a more youthful state, and has attracted some of the most prominent scientists in aging biology. If successful, the implications for healthcare, insurance, and human longevity would be difficult to overstate.

The Business Case for Moonshots

These moonshot companies share a common focus on markets with vast total addressable markets, where capturing even a fraction can deliver worthwhile returns relative to the risk.

Each is led by a founder or founding team with proven expertise in the key technical area and a strong visionary desire to turn the impossible into reality. At the same time, they have progressed to a point where their core technology is well validated, lowering the risk of failure, yet remain early enough to offer substantial valuation growth potential.

The moonshot investment category signifies something truly new in the history of capital allocation. These are not traditional growth companies. They are not optimizing an existing process or gaining market share in a specific industry. Instead, they aim to create markets that do not yet exist, using technologies that were not commercially viable a decade ago, at a pace that traditional corporate structures were not built to handle.